| Vivian Nell Hannon, | |
|
1241 Blount Ave, Guntersville, AL 35976-1831 | |
| (256) 582-6377 | |
| (256) 582-6376 |
| Full Name | Vivian Nell Hannon |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 30 Years |
| Location | 1241 Blount Ave, Guntersville, Alabama |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1346220191 | NPI | - | NPPES |
| 051031359 | Other | AL | BCBS OF AL |
| 000031359 | Medicaid | AL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 1066616 (Alabama) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Marshall Medical Centers | Boaz, AL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Vivian N Hannon | 6002879913 | 2 |
News Archive
Initial results of a study conducted at 100 centers worldwide indicate that belatacept, a first-in-class costimulation blocker can prevent the immune system rejecting new organs. The results also suggest that it may provide similar patient and graft survival to cyclosporine but with fewer side effects and superior kidney function after 12 months. The study, published today in the American Journal of Transplantation, provides the first findings to come from BENEFIT (Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial).
St. Jude Medical, Inc. has announced U.S. Food and Drug Administration (FDA) clearance of two spinal cord stimulation tripolar paddle leads for use with the Renew Neurostimulation System.
Kindred Healthcare, Inc. today announced its operating results for the third quarter ended September 30, 2009.
The Wall Street Journal on Monday examined how, although consumer-driven health plans have "motivated some workers to research what they are paying for medical care," the "employees' research often consists of going" to their managers for help.
› Verified 2 days ago
| Entity Name | Vivian N Hannon |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1841460375 PECOS PAC ID: 6002879913 Enrollment ID: O20041110001067 |
News Archive
Initial results of a study conducted at 100 centers worldwide indicate that belatacept, a first-in-class costimulation blocker can prevent the immune system rejecting new organs. The results also suggest that it may provide similar patient and graft survival to cyclosporine but with fewer side effects and superior kidney function after 12 months. The study, published today in the American Journal of Transplantation, provides the first findings to come from BENEFIT (Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial).
St. Jude Medical, Inc. has announced U.S. Food and Drug Administration (FDA) clearance of two spinal cord stimulation tripolar paddle leads for use with the Renew Neurostimulation System.
Kindred Healthcare, Inc. today announced its operating results for the third quarter ended September 30, 2009.
The Wall Street Journal on Monday examined how, although consumer-driven health plans have "motivated some workers to research what they are paying for medical care," the "employees' research often consists of going" to their managers for help.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Vivian Nell Hannon, 354 Cardessa Ln, Grant, AL 35747-9222 Ph: (256) 728-2330 | Vivian Nell Hannon, 1241 Blount Ave, Guntersville, AL 35976-1831 Ph: (256) 582-6377 |
News Archive
Initial results of a study conducted at 100 centers worldwide indicate that belatacept, a first-in-class costimulation blocker can prevent the immune system rejecting new organs. The results also suggest that it may provide similar patient and graft survival to cyclosporine but with fewer side effects and superior kidney function after 12 months. The study, published today in the American Journal of Transplantation, provides the first findings to come from BENEFIT (Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial).
St. Jude Medical, Inc. has announced U.S. Food and Drug Administration (FDA) clearance of two spinal cord stimulation tripolar paddle leads for use with the Renew Neurostimulation System.
Kindred Healthcare, Inc. today announced its operating results for the third quarter ended September 30, 2009.
The Wall Street Journal on Monday examined how, although consumer-driven health plans have "motivated some workers to research what they are paying for medical care," the "employees' research often consists of going" to their managers for help.
› Verified 2 days ago
Hollie Lane Sims, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 38 Rowe Dr, Guntersville, AL 35976 Phone: 256-571-8460 | |
Miss Jennifer Lynn Sanders, FNP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: Marshall Medical Center North, 8000 Alabama Hwy 69, Guntersville, AL 35976 Phone: 256-571-8108 | |
Mr. John Paul Mizelle, CRNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 2017 Obrig Ave, Guntersville, AL 35976 Phone: 256-582-2324 | |
John Grimes, CRNP Nurse Practitioner Medicare: May Accept Medicare Assignments Practice Location: 7938 Al Hwy 69, Suite 100, Guntersville, AL 35976 Phone: 256-571-8445 Fax: 256-571-8447 | |
Mrs. Jessica Wallace Howard, MSN, AGNP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 55 Rowe Dr, Suite C, Guntersville, AL 35976 Phone: 256-571-8807 | |
Katie Giles, WHNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 55 Rowe Dr Ste A, Guntersville, AL 35976 Phone: 256-571-8470 Fax: 256-571-8474 | |
Cathy Dawn Eubanks, CRNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1241 Blount Ave, Guntersville, AL 35976 Phone: 256-582-6377 Fax: 256-582-6377 |